Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC2A9 antisense RNA 1 (SLC2A9-AS1) is a long non-coding RNA gene located on chromosome 4 and is classified as an antisense RNA gene at the SLC2A9 locus[7][8]. The biological function of SLC2A9-AS1 has not been specified in the available research literature, and it has not been validated as a therapeutic target or biomarker[7][8]. It is likely transcribed in antisense orientation to the SLC2A9 transporter gene, which encodes the urate transporter GLUT9, but SLC2A9-AS1 itself is not implicated in urate transport or related clinical conditions. SLC2A9-AS1 should not be confused with the SLC2A9 protein or the transporter family, which have well-established roles in urate handling and associated disease[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC2A9 antisense RNA 1 (SLC2A9-AS1).